topoisomerase I/II inhibitor NEV-801
Term · Oncology and biomedicine · MLC-T-ONC-017267
A multi-targeted agent with potential antineoplastic activity. Upon administration, NEV-801 appears to selectively inhibit topoisomerase (Topo) I and II, and activates hypoxia-inducible factor 1 (HIF-1) transcription and the expression of vascular endothelial growth factor (VEGF) mRNA. NEV-801 is also able to overcome multidrug resistance (MDR) 1-mediated resistance.
| Identifier | MLC-T-ONC-017267 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TopI/II NEV-801 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017267",
"term": "topoisomerase I/II inhibitor NEV-801",
"field": "Oncology and biomedicine",
"definition": "A multi-targeted agent with potential antineoplastic activity. Upon administration, NEV-801 appears to selectively inhibit topoisomerase (Topo) I and II, and activates hypoxia-inducible factor 1 (HIF-1) transcription and the expression of vascular endothelial growth factor (VEGF) mRNA. NEV-801 is also able to overcome multidrug resistance (MDR) 1-mediated resistance.",
"synonyms": [
"TopI/II NEV-801"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/topoisomerase-i-ii-inhibitor-nev-801/"
}
Record 16,520 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.